Multidrug-Resistant Bacteria on Critically Ill Patients with Sepsis at Hospital Admission: Risk Factors and Effects on Hospital Mortality

References

• Capsoni N, Bellone P, Aliberti S, et al. Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria. Multidiscip Respir Med. 2019;14:23. doi:10.1186/s40248-019-0185-4
   PubMed Web of Science ®Google Scholar
• Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. doi:10.1164/rccm.201504-0781OC
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377. doi:10.1007/s00134-017-4683-6
   PubMed Web of Science ®Google Scholar
• Nguyen HB, Rivers EP, Abrahamian FM, et al. Emergency department sepsis education program and strategies to improve survival (ED-SEPSIS) working group. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med. 2006;48(1):28–54. doi:10.1016/j.annemergmed.2006.02.015
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign management guidelines committee. surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858–873. doi:10.1097/01.ccm.0000117317.18092.e4
   PubMed Web of Science ®Google Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. doi:10.1097/CCM.0000000000005337
   PubMed Web of Science ®Google Scholar
• Lisboa T, Nagel F. Infection with multi-resistant agents in the ICU: how to escape? Rev Bras Ter Intensiva. 2011;23(2):120–124. doi:10.1590/S0103-507X2011000200003
   PubMedGoogle Scholar
• Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118(1):146–155. doi:10.1378/chest.118.1.146
   PubMed Web of Science ®Google Scholar
• Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237–1248. doi:10.1378/chest.09-0087
   PubMed Web of Science ®Google Scholar
• Chen HC, Lin WL, Lin CC, et al. Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother. 2013;68(4):947–953. doi:10.1093/jac/dks475
   PubMed Web of Science ®Google Scholar
• Shorr AF, Micek ST, Welch EC, Doherty JA, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011;39(1):46–51. doi:10.1097/CCM.0b013e3181fa41a7
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49(2):760–766. doi:10.1128/AAC.49.2.760-766.2005
   PubMed Web of Science ®Google Scholar
• Tandon P, Delisle A, Topal JE, Garcia-Tsao G. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol. 2012;10(11):1291–1298. doi:10.1016/j.cgh.2012.08.017
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763–1771. doi:10.1001/jama.298.15.1763
   PubMed Web of Science ®Google Scholar
• Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666–674. doi:10.1056/NEJMoa055356
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596. doi:10.1186/s13054-014-0596-8
   PubMed Web of Science ®Google Scholar
• Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157(2):531–539. PMID: 9476869. doi:10.1164/ajrccm.157.2.9705064
   PubMed Web of Science ®Google Scholar
• Banerjee R, Strahilevitz J, Johnson JR, et al. Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community. Infect Control Hosp Epidemiol. 2013;34(9):947–953. doi:10.1086/671725
   PubMed Web of Science ®Google Scholar
• Pitout JD. Enterobacteriaceae that produce extended-spectrum β-lactamases and AmpC β-lactamases in the community: the tip of the iceberg? Curr Pharm Des. 2013;19(2):257–263. doi:10.2174/1381612811306020257
   PubMed Web of Science ®Google Scholar
• Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641–648. doi:10.1093/cid/cis942
   PubMed Web of Science ®Google Scholar
• van Duin D, Paterson DL. Multidrug-resistant bacteria in the community: trends and lessons learned. Infect Dis Clin North Am. 2016;30(2):377–390. doi:10.1016/j.idc.2016.02.004
   PubMed Web of Science ®Google Scholar
• Vardakas KZ, Rafailidis PI, Konstantelias AA, Falagas ME. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect. 2013;66(5):401–414. doi:10.1016/j.jinf.2012.10.028
   PubMed Web of Science ®Google Scholar
• Bodi M, Ardanuy C, Rello J. Impact of Gram-positive resistance on outcome of nosocomial pneumonia. Crit Care Med. 2001;29(4 Suppl):N82–N86. doi:10.1097/00003246-200104001-00005
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0. Basel: EUCAST; 2003.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Heinze G, Wallisch C, Dunkler D. Variable selection - A review and recommendations for the practicing statistician. Biom J. 2018;60(3):431–449. doi:10.1002/bimj.201700067
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268–274. doi:10.7326/M16-2607
   PubMed Web of Science ®Google Scholar
• Mathur MB, Ding P, Riddell CA, VanderWeele TJ. Web site and R package for computing E-values. Epidemiology. 2018;29(5):e45–e47. doi:10.1097/EDE.0000000000000864
   PubMed Web of Science ®Google Scholar
• Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med. 2014;42(11):2342–2349. doi:10.1097/CCM.0000000000000516
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Cauda R, Tumbarello M. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections. Future Microbiol. 2012;7(10):1173–1189. doi:10.2217/fmb.12.100
   PubMed Web of Science ®Google Scholar
• Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):S82–9. doi:10.1086/499406
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 2002;34(12):1600–1606. doi:10.1086/340616
   PubMed Web of Science ®Google Scholar
• Oxman D, Lohr K, Gupta E, Madara J, Len E, Hseih J. Incidence of multidrug resistant infections in emergency department patients with suspected sepsis. Am J Med Sci. 2020;360(6):650–655. doi:10.1016/j.amjms.2020.07.019
   PubMed Web of Science ®Google Scholar
• Faine BA, Harland KK, Porter B, Liang SY, Mohr N. A clinical decision rule identifies risk factors associated with antimicrobial-resistant urinary pathogens in the emergency department: a retrospective validation study. Ann Pharmacother. 2015;49(6):649–655. doi:10.1177/1060028015578259
   PubMed Web of Science ®Google Scholar
• Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840–851. doi:10.1056/NEJMra1208623
   PubMed Web of Science ®Google Scholar
• Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11. doi:10.4161/viru.27372
   PubMed Web of Science ®Google Scholar
• Aliberti S, Di Pasquale M, Zanaboni AM, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis. 2012;54(4):470–478. doi:10.1093/cid/cir840
   PubMed Web of Science ®Google Scholar
• Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. doi:10.1001/jama.2009.1754
   PubMed Web of Science ®Google Scholar
• Luzzaro F, Ortisi G, Larosa M, Drago M, Brigante G, Gesu G. Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study. Diagn Microbiol Infect Dis. 2011;69(4):363–369. doi:10.1016/j.diagmicrobio.2010.10.016
   PubMed Web of Science ®Google Scholar
• Rodríguez-Baño J, López-Prieto MD, Portillo MM, et al. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect. 2010;16(9):1408–1413. doi:10.1111/j.1469-0691.2009.03089.x
   PubMed Web of Science ®Google Scholar
• Kollef MH, Zilberberg MD, Shorr AF, et al. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect. 2011;62(2):130–135. doi:10.1016/j.jinf.2010.12.009
   PubMed Web of Science ®Google Scholar
• Fraimow HS, Tsigrelis C. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens. Crit Care Clin. 2011;27(1):163–205. doi:10.1016/j.ccc.2010.11.002
   PubMed Web of Science ®Google Scholar
• Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis. 2006;42(Suppl 4):S164–S172. doi:10.1086/500663
   PubMedGoogle Scholar
• Mehrad B, Clark NM, Zhanel GG, Lynch JP. Antimicrobial resistance in hospital-acquired gram-negative bacterial infections. Chest. 2015;147(5):1413–1421. doi:10.1378/chest.14-2171
   PubMed Web of Science ®Google Scholar
• Hussain A, Ranjan A, Nandanwar N, Babbar A, Jadhav S, Ahmed N. Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India. Antimicrob Agents Chemother. 2014;58(12):7240–7249. doi:10.1128/AAC.03320-14
   PubMed Web of Science ®Google Scholar
• Pannaraj PS, Bard JD, Cerini C, Weissman SJ. Pediatric carbapenem-resistant enterobacteriaceae in los angeles, California, a high-prevalence region in the United States. Pediatr Infect Dis J. 2015;34(1):11–16. doi:10.1097/INF.0000000000000471
   PubMed Web of Science ®Google Scholar
• Peirano G, Schreckenberger PC, Pitout JD. Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother. 2011;55(6):2986–2988. doi:10.1128/AAC.01763-10
   PubMed Web of Science ®Google Scholar
• Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, Restrepo MI. Multidrug-resistant pathogens in patients with pneumonia coming from the community. Curr Opin Pulm Med. 2016;22(3):219–226. doi:10.1097/MCP.0000000000000263
   PubMed Web of Science ®Google Scholar
• Shindo Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2013;188(8):985–995. doi:10.1164/rccm.201301-0079OC
   PubMed Web of Science ®Google Scholar
• Gross AE, Van Schooneveld TC, Olsen KM, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014;58(9):5262–5268. doi:10.1128/AAC.02582-14
   PubMed Web of Science ®Google Scholar
• Quintano Neira RA, Hamacher S, Japiassú AM. Epidemiology of sepsis in Brazil: incidence, lethality, costs, and other indicators for Brazilian unified health system hospitalizations from 2006 to 2015. PLoS One. 2018;13(4):e0195873. doi:10.1371/journal.pone.0195873
   PubMed Web of Science ®Google Scholar